Dr. Li's research is focused on how oncogenic mutations dysregulate cytokine signaling, cell stress response signaling, cellular metabolism in hematopoietic cells. She co-leads a collaboration through the Michigan Medicine-Peking University Health Science Center Joint Institute exploring the role of endoplasmic reticulum associated degradation (ERAD) in antigen presentation and immune evasion of multiple myeloma cells.
Qing Li, MD, PhD
Associate Professor of Internal Medicine
Associate Professor of Cell & Developmental Biology
Countries of Interest: China